Zobrazeno 1 - 10
of 35
pro vyhledávání: '"S. A Tiranova"'
Publikováno v:
Онкогематология, Vol 0, Iss 2, Pp 28-34 (2022)
Dacogen treatment results of 8 MDS patients and 2 CMML patients (a course dose — 100 mg/m2) are presented. Hematological response according to modified IWG criteria (complete remission - 2 pts, bone marrow remission — 1 pts, disease stabilization
Externí odkaz:
https://doaj.org/article/9bca993fc6684552b4c61f42e7d607e2
Autor:
S V Gritsaev, I I Kostroma, I M Zapreev, A V Shmidt, S A Tiranova, V A Balashova, I S Martynkevich, Zh V Chubukina, N Yu Semenova, A V Chechetkin
Publikováno v:
Терапевтический архив, Vol 88, Iss 7, Pp 104-108 (2016)
Secondary myeloid neoplasia may be a complication of intensive cytostatic therapy. The most common types of secondary neoplasias are acute myeloid leukemia and myelodysplastic syndrome. The development of secondary atypical chronic myeloid leukemia (
Externí odkaz:
https://doaj.org/article/009eb9158f6f4188ba4705f1e0425703
Autor:
I I Kostroma, S V Gritsaev, Zh Yu Sidorova, S A Tiranova, S P Svitina, Yu S Drizhun, Zh V Chubukina, I S Martynkevich, S I Kapustin, S S Bessmeltsev
Publikováno v:
Терапевтический архив, Vol 88, Iss 7, Pp 31-36 (2016)
Aim. To investigate the methylation status of the SOX7 and p15NK4b genes and Wnt signaling pathway antagonists in patients with acute myeloid leukemia (AML) in order to assess the association of the rate of aberrant methylation (AM) with the morpholo
Externí odkaz:
https://doaj.org/article/f7ad064eb0044f46b591e2622fc9c032
Autor:
S V Gritsaev, I I Kostroma, G M Ryadnova, S A Tiranova, Zh V Chubukina, V A Balashova, M N Zenina, I S Martynkevich, N A Potikhonova, K M Abdulkadyrov
Publikováno v:
Терапевтический архив, Vol 87, Iss 7, Pp 97-100 (2015)
This rare type of acute leukemia, blast cells of which express myeloid and/or lymphoid markers, is mainly diagnosed using flow cytometric findings. The paper describes a clinical case of mixed-phenotype acute leukemia, in which B-cell lymphoid antige
Externí odkaz:
https://doaj.org/article/0c420ee9fa5f44e8b8fb4a4f38fab805
Autor:
S V Gritsaev, I S Martynkevich, I S Ziuzgin, E V Kariagina, L S Martynenko, E V Petrova, N Iu Tsybakova, M P Ivanova, I I Kostroma, S A Tiranova, N A Potikhonova, K M Abdulkadyrov
Publikováno v:
Терапевтический архив, Vol 86, Iss 7, Pp 45-52 (2014)
AIM. To characterize the clinical and hematological variability of acute myeloid leukemia (AML) with t(8;21) and to identify the signs associated with the likelihood of its relapse. MATERIALS AND METHODS. The results of examining 44 patients aged 11
Externí odkaz:
https://doaj.org/article/c9705188e8214ff487de5afa236d89e1
Autor:
S V Gritsaev, I S Martynkevich, K M Abdulkadyrov, M P Ivanova, E V Petrova, I M Zapreeva, S A Tiranova, N A Potikhonova
Publikováno v:
Терапевтический архив, Vol 84, Iss 7, Pp 16-21 (2012)
Aim. To identify a category of persons with very low overall survival (OS) rates, whose intensive chemotherapy is unreasonable, amongst the patients with acute myeloid leukemia (AML) with extended forms of myelodysplastic syndrome (MDS) and complex k
Externí odkaz:
https://doaj.org/article/ffdef64d13b6447eb4c57b32d9376ff7
Autor:
Irina Stepanovna Martynkevich, Sergey Vasil'evich Gritsaev, Mikhail Viktorovich Moskalenko, Marina Petrovna Ivanova, Vasilisa Yur'evna Aksenova, Sof'ya Aleksandrovna Tiranova, Kudrat Mugutdinovich Abdulkadyrov, I S Martynkevich, S V Gritsayev, M V Moskalenko, M P Ivanova, V Yu Aksenova, S A Tiranova, K M Abdulkadyrov
Publikováno v:
Терапевтический архив, Vol 82, Iss 12, Pp 33-39 (2010)
Aim. To estimate the extent of FLT3 and NPM1 gene mutations and the impact of mutations of FLT3-ITD on the survival of patients with acute myeloid leukemias (AML). Materials and methods. The nucleus-containing cells of bone marrow and blood were stud
Externí odkaz:
https://doaj.org/article/361b220bc6a649f19cff5530e6b31352
Autor:
S V Gritsaev, K M Abdulkadyrov, S A Tiranova, S L Kapustin, I S Martynkevich, S S Bessmeltsev, V I Rugal, M P Bakai
Publikováno v:
Терапевтический архив, Vol 79, Iss 12, Pp 68-73 (2004)
Aim. To characterize patients with mixed myeloid neoplasias with proliferation of neutrophils, platelets and eosinophils. Material and methods. Examination and treatment results were analysed for patients with atypical myeloid leukemia (n = 4), myelo
Externí odkaz:
https://doaj.org/article/9ef157e8f358488c814d149555ee76e9
Autor:
A. M Radzhabova, S. V Voloshin, I. S Martynkevich, A. A Kuzyaeva, VA. Shuvaev, E. V Motyko, A. Y Kuvshinov, M. S Fominykh, A. V Schmidt, L. B Polushkina, M. P Bakay, S. A Tiranova, M. N Zenina, N. A Potihonova, SA. Kudryashova, V. A Balashova, J. V Chubukina, O. S Uspenskaya, E. V Karyagina, A. N Bogdanov, A. V Chechetkin
Publikováno v:
Genes & Cells. 14:55-61
Detection of FLT3 gene mutations in acute myeloid leukemia is now recognized as an unfavorable factor that affects the disease course, emerging the risk of relapses and overall survival shortening and disease-free survival of patients. The aim of the
Autor:
К М Abdulkadyrov, S V Gritsaev, S S Bessmeltsev, I S Matynkevich, S A Tiranova, M N Blinov, L V Stelmashenko, V V Pesterova
Publikováno v:
Терапевтический архив, Vol 79, Iss 7, Pp 85-87 (2004)
secondary myelodysplastic syndrome, multiple myeloma, complex karyotype impairments, treatment
Externí odkaz:
https://doaj.org/article/929cbdd7c6a14e3cbb56af8fb8cf9ada